Previous close | 311.88 |
Open | 310.65 |
Bid | 313.20 x 100 |
Ask | 314.60 x 100 |
Day's range | 306.47 - 315.77 |
52-week range | 176.34 - 413.20 |
Volume | |
Avg. volume | 740,288 |
Market cap | 23.621B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 54.10 |
EPS (TTM) | 5.80 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 321.27 |
Align Technology Reports Modest Revenue Growth but Misses EPS Estimates
Align Technology (ALGN) delivered earnings and revenue surprises of 8.08% and 2.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TEMPE, Ariz., April 24, 2024--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'24"). Q1'24 total revenues were $997.4 million, up 4.3% sequentially and up 5.8% year-over-year. Q1'24 Clear Aligner revenues were $817.3 milli